BR112014015401A2 - detecção de cepas da variante de meca de staphylococcus aureus resistente à meticilina - Google Patents

detecção de cepas da variante de meca de staphylococcus aureus resistente à meticilina

Info

Publication number
BR112014015401A2
BR112014015401A2 BR112014015401A BR112014015401A BR112014015401A2 BR 112014015401 A2 BR112014015401 A2 BR 112014015401A2 BR 112014015401 A BR112014015401 A BR 112014015401A BR 112014015401 A BR112014015401 A BR 112014015401A BR 112014015401 A2 BR112014015401 A2 BR 112014015401A2
Authority
BR
Brazil
Prior art keywords
variant
staphylococcus aureus
resistant staphylococcus
mecca
methicillin
Prior art date
Application number
BR112014015401A
Other languages
English (en)
Other versions
BR112014015401A8 (pt
Inventor
Saint-Patrice Cathy
Chambon Céline
Paillier François
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Publication of BR112014015401A2 publication Critical patent/BR112014015401A2/pt
Publication of BR112014015401A8 publication Critical patent/BR112014015401A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

resumo “detecção de cepas da variante de meca de staphylococcus aureus resistente à meticilina” a presente invenção fornece testes aprimorados para a detecção de staphylococcus aureus resistente à meticilina portando um gene meca variante. os testes são particularmente úteis para eliminar certos resultados falso negativos devido à presença desta variante no mrsa de amostras de paciente.
BR112014015401A 2011-12-23 2012-12-21 detecção de cepas da variante de meca de staphylococcus aureus resistente à meticilina BR112014015401A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11306776 2011-12-23
PCT/EP2012/076856 WO2013093106A1 (en) 2011-12-23 2012-12-21 Detection of meca variant strains of methicillin-resistant staphylococcus aureus

Publications (2)

Publication Number Publication Date
BR112014015401A2 true BR112014015401A2 (pt) 2017-06-13
BR112014015401A8 BR112014015401A8 (pt) 2017-07-04

Family

ID=47522617

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014015401A BR112014015401A8 (pt) 2011-12-23 2012-12-21 detecção de cepas da variante de meca de staphylococcus aureus resistente à meticilina

Country Status (13)

Country Link
US (2) US9394573B2 (pt)
EP (2) EP3450572A1 (pt)
JP (3) JP2015511116A (pt)
CN (1) CN104169437B (pt)
AU (2) AU2012356749B2 (pt)
BR (1) BR112014015401A8 (pt)
CA (1) CA2858284A1 (pt)
ES (1) ES2693158T3 (pt)
HK (1) HK1201888A1 (pt)
IL (1) IL233148B (pt)
IN (1) IN2014DN05831A (pt)
WO (1) WO2013093106A1 (pt)
ZA (1) ZA201404536B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10407739B2 (en) * 2013-09-23 2019-09-10 Quest Diagnostics Investments Incorporated Detection of methicillin-resistant Staphylococcus aureus in biological samples

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR823292A (fr) 1936-06-23 1938-01-18 Bakovenbouw Voorheen H P Den B Four à plusieurs zones de chauffage, par lesquelles les articles à cuire sont passés successivement, la température de chaque zone pouvant être réglée séparément
US4213893A (en) 1978-10-12 1980-07-22 Miles Laboratories, Inc. Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays
DE3041653A1 (de) 1980-11-05 1982-06-09 Hoechst Ag, 6000 Frankfurt Reaktive haertbare bindemittelmischung und deren verwendung zur herstellung von ueberzuegen
FI63596C (fi) 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
EP0531798B2 (en) 1983-01-10 2003-12-17 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
EP0222889B1 (en) 1985-05-15 1993-10-27 Amoco Corporation Cytidine analogs
US4751177A (en) 1985-06-13 1988-06-14 Amgen Methods and kits for performing nucleic acid hybridization assays
US4882269A (en) 1985-12-13 1989-11-21 Princeton University Amplified hybridization assay
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5766849A (en) 1989-07-11 1998-06-16 Gen-Probe Incorporated Methods of amplifying nucleic acids using promoter-containing primer sequence
DK0408295T3 (da) 1989-07-11 1996-09-16 Gen Probe Inc Fremgangsmåder til opformering af nukleinsyresekvenser
ATE137269T1 (de) 1990-01-26 1996-05-15 Abbott Lab Verbessertes verfahren zur amplifikation von nuklein säurezielsequenz, einsetzbar für die polymerase und ligasekettenreaktion
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
ZA936016B (en) 1992-08-24 1994-03-10 Akzo Nv Method for nucleic acid amplification
US6379897B1 (en) 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US5702895A (en) 1995-01-19 1997-12-30 Wakunaga Seiyaku Kabushiki Kaisha Method and kit for detecting methicillin-resistant Staphylococcus aureus
JP3957338B2 (ja) 1996-02-23 2007-08-15 株式会社カイノス 診断薬
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
ZA989950B (en) 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
EP1370694B1 (en) 2001-03-15 2007-01-24 Jacques Schrenzel Detection of methicillin-resistant staphylococcus aureus (mrsa)
CA2348042A1 (en) * 2001-06-04 2002-12-04 Ann Huletsky Sequences for detection and identification of methicillin-resistant staphylococcus aureus
DE60210621T2 (de) 2001-07-19 2007-03-08 Infectio Diagnostic (I.D.I.) Inc., Sainte-Foy Universelle methode und zusammensetzung zur schnellen lysierung von zellen zur freisetzung von nukleinsäuren und ihre detektion
ES2260578T3 (es) 2003-11-07 2006-11-01 FEDERAL REP GERMANY REPR BY MINISTRY HEALTH & SOC SECURITY, THE LATTER REPR BY PRES ROBERT KOCH INS. Metodo para detectar staphylococcus aureus resistente a la meticilina (mrsa).
WO2006028601A2 (en) 2004-07-26 2006-03-16 Nanosphere, Inc. Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture
WO2006111028A1 (en) 2005-04-21 2006-10-26 Uti Limited Partnership Pcr for mrsa sccmec typing
US8062850B2 (en) 2005-07-25 2011-11-22 Alere San Diego, Inc. Methods for multiplexing recombinase polymerase amplification
US7838221B2 (en) * 2005-10-11 2010-11-23 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA)
US11834720B2 (en) 2005-10-11 2023-12-05 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
CA2673958C (en) 2006-12-29 2014-04-08 Mayo Foundation For Medical Education And Research Methods for detecting methicillin-resistant s. aureus as well as primers, probes and kits for the same
CA2684570A1 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
US7888075B2 (en) 2007-07-31 2011-02-15 Quest Diagnostics Investments Incorporated Detection of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in biological samples
ES2686677T3 (es) * 2007-12-21 2018-10-19 Biomerieux Sa Detección de Staphylococcus aureus resistente a meticilina
FI121884B (fi) 2008-01-17 2011-05-31 Mobidiag Oy Menetelmä metisilliiniresistenttien stafylokokkien havaitsemiseksi ja tunnistamiseksi sekä menetelmään tarkoitettu koetin ja testipakkaus
WO2012078773A2 (en) * 2010-12-07 2012-06-14 Intelligent Medical Devices, Inc. Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec a
WO2013048583A2 (en) * 2011-05-24 2013-04-04 Elitech Holding B.V. Detection of methicillin-resistant staphylococcus aureus

Also Published As

Publication number Publication date
AU2012356749A1 (en) 2014-07-03
CA2858284A1 (en) 2013-06-27
US9394573B2 (en) 2016-07-19
AU2012356749B2 (en) 2018-08-02
AU2018256562A1 (en) 2018-11-22
AU2018256562B2 (en) 2021-01-28
CN104169437B (zh) 2017-07-11
JP2020072723A (ja) 2020-05-14
IL233148A0 (en) 2014-07-31
US20160281144A1 (en) 2016-09-29
EP2794917B1 (en) 2018-08-08
ZA201404536B (en) 2016-07-27
HK1201888A1 (en) 2015-09-11
US20130164752A1 (en) 2013-06-27
BR112014015401A8 (pt) 2017-07-04
ES2693158T3 (es) 2018-12-07
EP3450572A1 (en) 2019-03-06
JP2018038402A (ja) 2018-03-15
US10829825B2 (en) 2020-11-10
WO2013093106A1 (en) 2013-06-27
IN2014DN05831A (pt) 2015-06-26
JP2015511116A (ja) 2015-04-16
EP2794917A1 (en) 2014-10-29
IL233148B (en) 2019-11-28
CN104169437A (zh) 2014-11-26

Similar Documents

Publication Publication Date Title
MA40682A (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
CR20150393A (es) Moleculas biespecíficas de union a antígeno activadoras de células t
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
BR112015001592A8 (pt) análise de imagem e medidas de amostras biológicas
BR112018010360A2 (pt) fragmentos fab de fator de complemento anti-c1q e utilizações dos mesmos
BR112016025627A2 (pt) biomarcadores e combinações dos mesmos para diagnóstico de tuberculose
BR112016006312A2 (pt) método e kit para determinar a presença ou ausência de staphylococcus aureus resistente à meticilina em uma amostra biológica
CY1120535T1 (el) Δοτες νιτροξυλιου με βελτιωμενο θεραπευτικο δεικτη
MA39248B1 (fr) Anticorps anti-jagged1 et procédés d'utilisation correspondants
CL2017002176A1 (es) Identificación bacteriana y prueba de susceptibilidad antimicrobiana.
EA201490778A1 (ru) АНТИТЕЛА ПРОТИВ HtrA1 И СПОСОБЫ ПРИМЕНЕНИЯ
PE20161032A1 (es) Anticuerpos anti-tau(ps422) humanizados y metodos de utilizacion
MY167717A (en) Diagnostic device for evaporated fuel processing device
CY1122980T1 (el) Φαρμακευτικο σκευασμα που περιεχει ινοσιτολη
BR112014008550A2 (pt) citramida rasagilina
AU2013245387A8 (en) Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ type xxi
BR112017021186A2 (pt) ?método para detectar a presença de bactérias produtoras de beta-lactamase?
EP3172667A4 (en) System for an instruction set agnostic runtime architecture
BR112014008555A2 (pt) r(+)-n-formil-propargil-aminoindano
BR112013017499A2 (pt) combinação de sirosingopina e inibidores mitocondriais para o tratamento de câncer e imunossupressão
UY34897A (es) Profarmacos de inhibidores peptidicos de expoxi cetona proteasa
BR112017006552A2 (pt) composições e métodos para inibir a atividade biológica de biomoléculas solúveis
IN2014DN09450A (pt)
BR112016016737A2 (pt) Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]